Acta Oncologica, Volume 59, Issue 3 (2020)

Browse this journal
Sample our Bioscience journals, sign in here to start your access, Latest two full volumes FREE to you for 14 days

Acta Oncologica, Volume 59, Issue 3 (2020)

See all volumes and issues
Vol 62, 2023 Vol 61, 2022 Vol 60, 2021 Volume 59, 2020 Vol 58, 2019 Vol 57, 2018 Vol 56, 2017 Vol 55, 2016 Vol 54, 2015 Vol 53, 2014 Vol 52, 2013 Vol 51, 2012 Vol 50, 2011 Vol 49, 2010 Vol 48, 2009 Vol 47, 2008 Vol 46, 2007 Vol 45, 2006 Vol 44, 2005 Vol 43, 2004 Vol 42, 2003 Vol 41, 2002 Vol 40, 2001 Vol 39, 2000 Vol 38, 1999 Vol 37, 1998 Vol 36, 1997 Vol 35, 1996 Vol 34, 1995 Vol 33, 1994 Vol 32, 1993 Vol 31, 1992 Vol 30, 1991 Vol 29, 1990 Vol 28, 1989 Vol 27, 1988 Vol 26, 1987 Vol 25, 1986 Vol 24, 1985 Vol 23, 1984 Vol 22, 1983 Vol 21, 1982 Vol 20, 1981 Vol 19, 1980 Vol 18, 1979 Vol 17, 1978 Vol 16, 1977 Vol 15, 1976 Vol 14, 1975 Vol 13, 1974 Vol 12, 1973 Vol 11, 1972 Vol 10, 1971 Vol 9, 1970 Vol 8, 1969 Vol 7, 1968 Vol 6, 1967 Vol 5, 1966 Vol 4, 1966 Vol 3, 1965 Vol 2, 1964 Vol 1, 1963
Download citations Download PDFs Download issue

EDITORIAL

Editorial
Immune checkpoint inhibitors in cancer treatment and potential effect modification by age
Hanna Eriksson & Karin E. Smedby
Pages: 247-248
Published online: 08 Feb 2020
CitationforImmune checkpoint inhibitors in cancer treatment and potential effect modification by age | Full Text | References | PDF (241.3 KB) | EPUB
  • 1037 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access

REVIEW: MEDICAL ONCOLOGY

Review
Influence of age on the efficacy of immune checkpoint inhibitors in advanced cancers: a systematic review and meta-analysis
Kiichiro Ninomiya, Isao Oze, Yuka Kato, Toshio Kubo, Eiki Ichihara, Kammei Rai, Kadoaki Ohashi, Toshiyuki Kozuki, Masahiro Tabata, Yoshinobu Maeda, Katsuyuki Kiura & Katsuyuki Hotta
Pages: 249-256
Published online: 29 Nov 2019
AbstractforInfluence of age on the efficacy of immune checkpoint inhibitors in advanced cancers: a systematic review and meta-analysis | Full Text | References | PDF (922 KB) | EPUB | Supplemental
  • 2953 Views
  • 24 CrossRef citations
  • 0Altmetric
Free Access

LETTER TO THE EDITOR: MEDICAL ONCOLOGY

Letter
Clinical benefit to programmed death-1 inhibition for non-small-cell lung cancer is associated with higher blood eosinophil levels
A. Sibille, M. Henket, J. L. Corhay, R. Louis & B. Duysinx
Pages: 257-259
Published online: 22 Nov 2019
First Page PreviewforClinical benefit to programmed death-1 inhibition for non-small-cell lung cancer is associated with higher blood eosinophil levels | Full Text | References | PDF (324.2 KB) | EPUB
  • 813 Views
  • 7 CrossRef citations
  • 0Altmetric
Free Access

ORIGINAL ARTICLES: MEDICAL ONCOLOGY

Article
Terminal digit preference: a source of measurement error in breast cancer diameter reporting
Kaitlyn M. Tsuruda, Solveig Hofvind, Lars A. Akslen, Solveig R. Hoff & Marit B. Veierød
Pages: 260-267
Published online: 30 Sep 2019
AbstractforTerminal digit preference: a source of measurement error in breast cancer diameter reporting | Full Text | References | PDF (1.9 MB) | EPUB | Supplemental
  • 1908 Views
  • 6 CrossRef citations
  • 0Altmetric
Open Access
Article
High RSF1 protein expression is an independent prognostic feature in prostate cancer
Doris Höflmayer, Moslim Hamuda, Cornelia Schroeder, Claudia Hube-Magg, Ronald Simon, Cosima Göbel, Andrea Hinsch, Sören Weidemann, Katharina Möller, Jacob R. Izbicki, Frank Jacobsen, Tim Mandelkow, Niclas C. Blessin, Florian Lutz, Florian Viehweger, Guido Sauter, Eike Burandt, Patrick Lebok, Maximilian Lennartz, Christoph Fraune, Sarah Minner, Sarah Bonk, Hartwig Huland, Markus Graefen, Thorsten Schlomm & Franziska Büscheck
Pages: 268-273
Published online: 05 Nov 2019
AbstractforHigh RSF1 protein expression is an independent prognostic feature in prostate cancer | Full Text | References | PDF (1.4 MB) | EPUB | Supplemental
  • 990 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Article
Knowledge-based planning for oesophageal cancers using a model trained with plans from a different treatment planning system
Yoshihiro Ueda, Masayoshi Miyazaki, Iori Sumida, Shingo Ohira, Mikoto Tamura, Hajime Monzen, Haruhi Tsuru, Shoki Inui, Masaru Isono, Kazuhiko Ogawa & Teruki Teshima
Pages: 274-283
Published online: 22 Nov 2019
AbstractforKnowledge-based planning for oesophageal cancers using a model trained with plans from a different treatment planning system | Full Text | References | PDF (1.7 MB) | EPUB
  • 1403 Views
  • 11 CrossRef citations
  • 0Altmetric
Free Access
Article
Metastatic colorectal carcinomas with high SATB2 expression are associated with better prognosis and response to chemotherapy: a population-based Scandinavian study
Artur Mezheyeuski, Fredrik Ponten, Per-Henrik Edqvist, Magnus Sundström, Ulf Thunberg, Camilla Qvortrup, Per Pfeiffer, Halfdan Sorbye, Bengt Glimelius & Anca Dragomir
Pages: 284-290
Published online: 26 Nov 2019
AbstractforMetastatic colorectal carcinomas with high SATB2 expression are associated with better prognosis and response to chemotherapy: a population-based Scandinavian study | Full Text | References | PDF (1 MB) | EPUB | Supplemental
  • 3035 Views
  • 11 CrossRef citations
  • 0Altmetric
Open Access
Article
Impact of body fat distribution and sarcopenia on the overall survival in patients with spinal metastases receiving radiotherapy treatment: a prospective cohort study
B. J. Pielkenrood, P. R. van Urk, J. M. van der Velden, N. Kasperts, J. J. C. Verhoeff, G. H. Bol, H. M. Verkooijen & J. J. Verlaan
Pages: 291-297
Published online: 23 Nov 2019
AbstractforImpact of body fat distribution and sarcopenia on the overall survival in patients with spinal metastases receiving radiotherapy treatment: a prospective cohort study | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 2073 Views
  • 8 CrossRef citations
  • 0Altmetric
Open Access
Article
Phase II study of gemcitabine, oxaliplatin and capecitabine in patients with KRAS exon 2 mutated biliary tract cancers
Lars H. Jensen, Rikke Fredslund Andersen, Lene Byriel, Eva Fernebro, Anders Jakobsen, Jan Lindebjerg, Lise Nottelmann, John Ploen & Torben F. Hansen
Pages: 298-301
Published online: 14 Dec 2019
AbstractforPhase II study of gemcitabine, oxaliplatin and capecitabine in patients with KRAS exon 2 mutated biliary tract cancers | Full Text | References | PDF (457.6 KB) | EPUB | Supplemental
  • 1260 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access

LETTERS TO THE EDITOR: MEDICAL ONCOLOGY

Letter
Successful treatment of central nervous system involved Erdheim–Chester disease by intermediate-dose cytarabine as first-line therapy
Ji-Nuo Wang, Yu Qiu, Na Niu, Yan Zhang, Jian Li, Dao-bin Zhou & Xin-Xin Cao
Pages: 302-305
Published online: 27 Sep 2019
First Page PreviewforSuccessful treatment of central nervous system involved Erdheim–Chester disease by intermediate-dose cytarabine as first-line therapy | Full Text | References | PDF (1.1 MB) | EPUB
  • 1044 Views
  • 6 CrossRef citations
  • 0Altmetric
Free Access
Letter
Regenerative nodular hyperplasia after T-DM1: consequences from sinusoidal endothelium damages
Soraya Benguerfi, Véronique Diéras, Mario Campone, Jean-François Mosnier & Marie Robert
Pages: 306-309
Published online: 26 Sep 2019
First Page PreviewforRegenerative nodular hyperplasia after T-DM1: consequences from sinusoidal endothelium damages | Full Text | References | PDF (831 KB) | EPUB
  • 1483 Views
  • 4 CrossRef citations
  • 0Altmetric
Free Access
Letter
Combination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma
Kalle E. Mattila, Pia Vihinen, Susan Ramadan, Tanja Skyttä, Leena Tiainen, Meri-Sisko Vuoristo, Kristiina Tyynelä-Korhonen, Jussi Koivunen, Laura Kohtamäki, Siru Mäkelä & Micaela Hernberg
Pages: 310-314
Published online: 28 Sep 2019
First Page PreviewforCombination chemotherapy with temozolomide, lomustine, vincristine and interferon-alpha (TOL-IFN) plus vemurafenib or TOL-IFN as first-line treatment for patients with advanced melanoma | Full Text | References | PDF (1.1 MB) | EPUB | Supplemental
  • 1300 Views
  • 5 CrossRef citations
  • 0Altmetric
Free Access
Letter
Carcinoid heart failure in a duodenal neuroendocrine tumor: role of cardiac surgery in a challenging patient and brief review of the literature
Anna La Salvia, Maria Pia Brizzi, Elena Trevisi, Francesco Parisi, Leonardo Muratori, Francesco Atzeni, Massimo Di Maio & Giorgio V. Scagliotti
Pages: 315-319
Published online: 04 Oct 2019
First Page PreviewforCarcinoid heart failure in a duodenal neuroendocrine tumor: role of cardiac surgery in a challenging patient and brief review of the literature | Full Text | References | PDF (548.3 KB) | EPUB
  • 1044 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Letter
Delay in adjuvant chemoradiation impacts survival outcome in glioblastoma multiforme patients
Mahadev Potharaju, Anugraha Mathavan, Balamurugan Mangaleswaran, Siddhartha Ghosh & Reginald John
Pages: 320-323
Published online: 01 Oct 2019
First Page PreviewforDelay in adjuvant chemoradiation impacts survival outcome in glioblastoma multiforme patients | Full Text | References | PDF (461.7 KB) | EPUB
  • 963 Views
  • 3 CrossRef citations
  • 0Altmetric
Free Access
Letter
Patients’ preferences and perceptions of lung cancer treatment decision making: results from Okayama lung cancer study group trial 1406
Go Makimoto, Katsuyuki Hotta, Isao Oze, Kiichiro Ninomiya, Masamoto Nakanishi, Naofumi Hara, Hirohisa Kano, Hiromi Watanabe, Yusuke Hata, Kazuya Nishii, Takamasa Nakasuka, Junko Itano, Takashi Ninomiya, Toshio Kubo, Kadoaki Ohashi, Eiki Ichihara, Daisuke Minami, Akiko Sato, Masahiro Tabata, Yoshinobu Maeda & Katsuyuki Kiura
Pages: 324-328
Published online: 25 Oct 2019
First Page PreviewforPatients’ preferences and perceptions of lung cancer treatment decision making: results from Okayama lung cancer study group trial 1406 | Full Text | References | PDF (548.1 KB) | EPUB | Supplemental
  • 1658 Views
  • 2 CrossRef citations
  • 0Altmetric
Free Access
Letter
17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence: a Danish population-based study
Lindsay J. Collin, Sinna P. Ulrichsen, Thomas P. Ahern, Michael Goodman, Lauren E. McCullough, Lance A. Waller, Kristina Bang Christensen, Per Damkier, Stephen Hamilton-Dutoit, Kristina L. Lauridsen, Rami Yacoub, Peer M. Christiansen, Bent Ejlertsen, Henrik Toft Sørensen, Deirdre P. Cronin-Fenton & Timothy L. Lash
Pages: 329-333
Published online: 31 Oct 2019
First Page Previewfor17β-Hydroxysteroid dehydrogenase 1:2 and breast cancer recurrence: a Danish population-based study | Full Text | References | PDF (1.2 MB) | EPUB | Supplemental
  • 1639 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Letter
Cutaneous adult T-cell leukemia/lymphoma presenting as sweet syndrome
Alana Deutsch, Mark Jacobson & Beth N. McLellan
Pages: 334-335
Published online: 18 Nov 2019
CitationforCutaneous adult T-cell leukemia/lymphoma presenting as sweet syndrome | Full Text | References | PDF (802 KB) | EPUB
  • 862 Views
  • 1 CrossRef citations
  • 0Altmetric
Free Access
Letter
IMPROVE-IT2: implementing noninvasive circulating tumor DNA analysis to optimize the operative and postoperative treatment for patients with colorectal cancer – intervention trial 2. Study protocol
Jesper Nors, Tenna Vesterman Henriksen, Kåre Andersson Gotschalck, Therese Juul, Jes Søgaard, Lene Hjerrild Iversen & Claus Lindbjerg Andersen
Pages: 336-341
Published online: 10 Jan 2020
First Page PreviewforIMPROVE-IT2: implementing noninvasive circulating tumor DNA analysis to optimize the operative and postoperative treatment for patients with colorectal cancer – intervention trial 2. Study protocol | Full Text | References | PDF (1.5 MB) | EPUB | Supplemental
  • 3303 Views
  • 24 CrossRef citations
  • 0Altmetric
Free Access

ORIGINAL ARTICLES: SURVIVORSHIP

Article
Demographic, clinical and lifestyle-related correlates of accelerometer assessed physical activity and fitness in newly diagnosed patients with head and neck cancer
J. A. J. Douma, I. M. Verdonck-de Leeuw, C. R. Leemans, F. Jansen, J. A. Langendijk, R. J. Baatenburg de Jong, C. H. J. Terhaard, R. P. Takes, M. J. Chinapaw, T. M. Altenburg & L. M. Buffart
Pages: 342-350
Published online: 12 Oct 2019
AbstractforDemographic, clinical and lifestyle-related correlates of accelerometer assessed physical activity and fitness in newly diagnosed patients with head and neck cancer | Full Text | References | PDF (1.2 MB) | EPUB
  • 2508 Views
  • 12 CrossRef citations
  • 0Altmetric
Open Access
Article
Parents’ needs of support following the loss of a child to cancer: a Swedish, prospective, longitudinal, multi-centre study
Emma Hovén, Josefin Hagström, Ulrika Pöder, Helena Grönqvist & Louise von Essen
Pages: 351-357
Published online: 08 Nov 2019
AbstractforParents’ needs of support following the loss of a child to cancer: a Swedish, prospective, longitudinal, multi-centre study | Full Text | References | PDF (1.3 MB) | EPUB | Supplemental
  • 2459 Views
  • 2 CrossRef citations
  • 0Altmetric
Open Access
Article
Item-level psychometrics of a brief self-reported memory problem screening measure in breast cancer survivors
Pascal Jean-Pierre, Ying Cheng & Raheem J. Paxton
Pages: 358-364
Published online: 08 Nov 2019
AbstractforItem-level psychometrics of a brief self-reported memory problem screening measure in breast cancer survivors | Full Text | References | PDF (1.1 MB) | EPUB
  • 1112 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access
Article
Validation of the Lymphoedema Quality of Life Questionnaire (LYMQOL) in Swedish cancer patients
Madelene Wedin, Mats Fredrikson, Eva Ahlner, Annika Falk, Åsa Sandström, Gabriel Lindahl, Per Rosenberg & Preben Kjølhede
Pages: 365-371
Published online: 18 Dec 2019
AbstractforValidation of the Lymphoedema Quality of Life Questionnaire (LYMQOL) in Swedish cancer patients | Full Text | References | PDF (770.3 KB) | EPUB | Supplemental
  • 5199 Views
  • 15 CrossRef citations
  • 0Altmetric
Open Access

Explore articles